Lexaria Bioscience (LEXX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Lexaria Bioscience (LEXX) is Strong Underperform.

The composite score behind that read is -0.51, weighing +0.25 of bullish evidence against -0.56 bearish.

Lexaria Bioscience last closed at $2.77, -3.82% on the session.

Against the IVW growth benchmark the position is -4.74% over the forecast window.

The read is built from 13 underlying insights — 1 bullish and 12 bearish.

Agreement across those insights is 92%.

16 graded predictions for LEXX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Lexaria Bioscience is classified under Health Care / Pharmaceuticals, with a market capitalisation of $4.76M.

StockMap tracks Lexaria Bioscience as the 118th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Lexaria Bioscience ranks 114th of 128 in the group, against a group median of -0.24.